Company / Accounts Receivable
ORTHOPEDIATRICS CORP Accounts Receivable History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$53.8M
FY2025
5-year range
$17.9M / $53.8M
FY2021-FY2025
Trend
+27.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Accounts Receivable has increased for 8 consecutive years, from $6M in FY2017 to $54M in FY2025.
Based on SEC 10-K filings.
$54M in FY2025 with a 5-year CAGR of +25.6%.
Improved from $35M to $54M over the past 2 years.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +29.5%
- 5-Year CAGR
- +25.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- ORTHOPEDIATRICS CORP's accounts receivable has grown for 8 consecutive years.
- 5-year CAGR of +25.6%, indicating consistent growth.
- In FY2025, accounts receivable increased 27.1% year-over-year.
- Lowest accounts receivable in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $53.8M | +27.1% |
| FY2024 | $42.4M | +22.4% |
| FY2023 | $34.6M | +39.6% |
| FY2022 | $24.8M | +38.2% |
| FY2021 | $17.9M | +4.2% |
| FY2020 | $17.2M | +7.6% |
| FY2019 | $16.0M | +77.8% |
| FY2018 | $9.0M | +60.6% |
| FY2017 | $5.6M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026